DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 2DR REDDYS
02 2AMNEAL PHARMS
03 1APOTEX
04 1FLORIDA
05 2GLENMARK SPECLT
06 1HIKMA
07 2JANSSEN BIOTECH
08 2MSN
09 2MYLAN
10 2NOVUGEN
11 2QILU
12 1RISING
13 1SUN PHARM
14 3TEVA PHARMS USA
15 1WOCKHARDT BIO AG
01 25TABLET;ORAL
01 1DISCN
02 24RX
01 22ABIRATERONE ACETATE
02 1YONSA
03 2ZYTIGA
01 22No
02 3Yes
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Approval Date : 2020-05-18
Application Number : 208416
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
RLD : No
TE Code : AB
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 2023-09-01
Application Number : 208416
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 250MG
Approval Date : 2019-01-07
Application Number : 208327
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Brand Name : ABIRATERONE ACETATE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 2020-12-23
Application Number : 208327
RX/OTC/DISCN : RX
RLD : No
TE Code : AB